Healthcare provider profile · identity verified

Ashley Denise Lang

Nurse Practitioner · CONROE, TX · NPI 1356003404

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

BrandGenericClaimsBeneficiaries
Atorvastatin CalciumAtorvastatin Calcium13763
Levothyroxine SodiumLevothyroxine Sodium8335
GabapentinGabapentin8037
Amlodipine BesylateAmlodipine Besylate7635
Pantoprazole SodiumPantoprazole Sodium6826
FurosemideFurosemide6743
Montelukast SodiumMontelukast Sodium6022
CarvedilolCarvedilol5425
Losartan PotassiumLosartan Potassium5025
Metoprolol SuccinateMetoprolol Succinate4921
Metoprolol TartrateMetoprolol Tartrate4918
NystatinNystatin4821
Metformin HclMetformin Hcl4619
Rosuvastatin CalciumRosuvastatin Calcium4520
OmeprazoleOmeprazole4321
LisinoprilLisinopril4223
FluconazoleFluconazole4124
Potassium ChloridePotassium Chloride4122
Tamsulosin HclTamsulosin Hcl4120
Tramadol HclTramadol Hcl4016
Trazodone HclTrazodone Hcl4018
Albuterol Sulfate HfaAlbuterol Sulfate3812
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav3728
AzithromycinAzithromycin3533
EliquisApixaban3521
Buspirone HclBuspirone Hcl3217
Ciprofloxacin HclCiprofloxacin Hcl3230
MirtazapineMirtazapine3016
Nifedipine ErNifedipine3012
ClopidogrelClopidogrel Bisulfate2914
Doxycycline HyclateDoxycycline Hyclate2925
MethylprednisoloneMethylprednisolone2925
Ropinirole HclRopinirole Hcl2911
Metformin Hcl ErMetformin Hcl2812
Ondansetron OdtOndansetron2724
GlimepirideGlimepiride26suppressed
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst2624
Duloxetine HclDuloxetine Hcl25suppressed
FamotidineFamotidine2412
Fluticasone PropionateFluticasone Propionate23suppressed
Warfarin SodiumWarfarin Sodium21suppressed
Hydralazine HclHydralazine Hcl20suppressed
KetoconazoleKetoconazole20suppressed
LevetiracetamLevetiracetam2012
Sertraline HclSertraline Hcl2012
Citalopram HbrCitalopram Hydrobromide19suppressed
Hydroxyzine HclHydroxyzine Hcl19suppressed
JanuviaSitagliptin Phosphate19suppressed
LorazepamLorazepam19suppressed
Escitalopram OxalateEscitalopram Oxalate18suppressed
Oxybutynin Chloride ErOxybutynin Chloride18suppressed
SpironolactoneSpironolactone18suppressed
XareltoRivaroxaban18suppressed
BumetanideBumetanide17suppressed
Isosorbide Mononitrate ErIsosorbide Mononitrate17suppressed
PrednisonePrednisone1711
TorsemideTorsemide17suppressed
Acetaminophen-CodeineAcetaminophen With Codeine16suppressed
Donepezil HclDonepezil Hcl16suppressed
HydrochlorothiazideHydrochlorothiazide16suppressed
LactuloseLactulose16suppressed
ValsartanValsartan16suppressed
Lantus SolostarInsulin Glargine,hum.Rec.Anlog15suppressed
Tizanidine HclTizanidine Hcl15suppressed
CelecoxibCelecoxib14suppressed
EzetimibeEzetimibe14suppressed
Memantine HclMemantine Hcl14suppressed
MetolazoneMetolazone14suppressed
Pravastatin SodiumPravastatin Sodium14suppressed
SymbicortBudesonide/Formoterol Fumarate14suppressed
AllopurinolAllopurinol13suppressed
TeriflunomideTeriflunomide13suppressed
Pioglitazone HclPioglitazone Hcl12suppressed
ClonazepamClonazepam11suppressed
Diclofenac SodiumDiclofenac Sodium11suppressed
Dicyclomine HclDicyclomine Hcl11suppressed
Doxazosin MesylateDoxazosin Mesylate11suppressed
GlipizideGlipizide11suppressed
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim11suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

YearGeneral PaymentsMain payerExplicit productsCompany overlapsPart D coverage
2025
2024 Complete

Questions to ask

Questions you could discuss with your doctor

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Loaded source releases

DatasetYearPublicationSource
CMS Open Payments — General Payments 2025 2026-06-30 Original source
Medicare Part D Prescribers by Provider and Drug 2024 2026-05-06 Original source
NPPES Data Dissemination V2 current / reference data 2026-08-10 Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error